Moderna
MRNA
#1601
Rank
C$14.57 B
Marketcap
$37.71
Share price
-0.62%
Change (1 day)
-74.00%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Cash on Hand

Cash on Hand as of December 2024 : C$9.73 Billion

According to Moderna 's latest financial reports the company has C$9.73 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Moderna - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$10.08 B-11.66%
2023-12-31C$11.41 B-15.07%
2022-12-31C$13.43 B-1.71%
2021-12-31C$13.67 B132.68%
2020-12-31C$5.87 B307.86%
2019-12-31C$1.44 B-30.49%
2018-12-31C$2.07 B118.04%
2017-12-31C$0.95 B-33.16%
2016-12-31C$1.42 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$0.10 B-98.92%๐Ÿ‡บ๐Ÿ‡ธ USA
C$18.96 B 94.86%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.41 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
C$3.73 B-61.64%๐Ÿ‡บ๐Ÿ‡ธ USA
C$18.49 B 90.05%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$0.76 B-92.13%๐Ÿ‡บ๐Ÿ‡ธ USA
C$33.97 B 249.07%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA